The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDerwent London Regulatory News (DLN)

Share Price Information for Derwent London (DLN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2,218.00
Bid: 2,230.00
Ask: 2,242.00
Change: -54.00 (-2.38%)
Spread: 12.00 (0.538%)
Open: 2,250.00
High: 2,274.00
Low: 2,218.00
Prev. Close: 2,272.00
DLN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

ACQUISITION OF BLUE STAR HOUSE, BRIXTON SW9

30 Jan 2020 07:00

RNS Number : 3581B
Derwent London PLC
30 January 2020
 

Derwent London plc ("Derwent London" / "the Group")ACQUISITION OF BLUE STAR HOUSE, BRIXTON SW9

Derwent London is pleased to announce that it has exchanged contracts to acquire the freehold interest in Blue Star House, 234-244 Stockwell Road, Brixton SW9 for £38.1m before costs. The 53,750 sq ft eleven-storey building comprises multi-let office space, including two vacant floors, with restaurant and leisure accommodation at ground/podium level. The rent on acquisition is £0.8m, equating to a low average rent of £14.50 per sq ft on the occupied office space. The acquisition price equates to a capital value of £710 per sq ft.

 

The property, which sits on a 0.7 acre site that includes a surface car park, is located immediately opposite the Brixton O2 Academy. Brixton underground and overground stations are only a few minutes' walk away with travel times to Victoria and Oxford Circus of just 7 and 11 minutes respectively.

 

Vacant possession can be achieved in the next few years and there is scope to redevelop the site with a significantly larger scheme.

 

Paul Williams, Chief Executive at Derwent London, said:

"We are delighted to have acquired Blue Star House and added Brixton as a location within our portfolio. With its excellent connectivity to the West End, we see this as an exciting addition to our substantial development pipeline."

- ends -

 

For further information, please contact:

 

Derwent London

Tel: +44 (0)20 7659 3000

 

Paul Williams, Chief Executive

David Silverman, Director

Quentin Freeman, Head of Investor Relations

 

Brunswick Group

Tel: +44 (0)20 7404 5959

 

 

Nina Coad

Emily Trapnell

 

 

 

 

Notes to editors

 

 

Derwent London plc

Derwent London plc owns 84 buildings in a commercial real estate portfolio predominantly in central London valued at £5.4 billion (including joint ventures) as at 30 June 2019, making it the largest London-focused real estate investment trust (REIT).

 

Our experienced team has a long track record of creating value throughout the property cycle by regenerating our buildings via development or refurbishment, effective asset management and capital recycling.

 

We typically acquire central London properties off-market with low capital values and modest rents in improving locations, most of which are either in the West End or the Tech Belt. We capitalise on the unique qualities of each of our properties - taking a fresh approach to the regeneration of every building with a focus on anticipating tenant requirements and an emphasis on design.

 

Reflecting and supporting our long-term success, the business has a strong balance sheet with modest leverage, a robust income stream and flexible financing.

 

As part of our commitment to lead the industry in mitigating climate change, in October 2019, Derwent London became the first UK REIT to sign a Green Revolving Credit Facility. At the same time, we also launched our Green Finance Framework and signed the Better Buildings Partnership's climate change commitment. The Group is a member of the 'RE100' which recognises Derwent London as an influential company, committed to 100% renewable power by purchasing renewable energy, a key step in becoming a net zero carbon business. Derwent London is one of only a few property companies worldwide to have science-based carbon targets validated by the Science Based Targets initiative (SBTi).

 

Landmark schemes in our 5.7 million sq ft portfolio include Brunel Building W2, White Collar Factory EC1, Angel Building EC1, 1-2 Stephen Street W1, Horseferry House SW1 and Tea Building E1.

 

In 2019, the Group has won several awards including EG Offices Company of the Year, the CoStar West End Deal of the Year for Brunel Building, Westminster Business Council's Best Achievement in Sustainability award and topped the real estate sector and was placed ninth overall in the Management Today 2019 awards for 'Britain's Most Admired Companies'. In 2013 the Company launched a voluntary Community Fund and has to date supported 96 community projects in the West End and the Tech Belt.

 

The Company is a public limited company, which is listed on the London Stock Exchange and incorporated and domiciled in the UK. The address of its registered office is 25 Savile Row, London, W1S 2ER.

 

For further information see www.derwentlondon.com or follow us on Twitter at @derwentlondon

 

 

Forward-looking statements

This document contains certain forward-looking statements about the future outlook of Derwent London. By their nature, any statements about future outlook involve risk and uncertainty because they relate to events and depend on circumstances that may or may not occur in the future. Actual results, performance or outcomes may differ materially from any results, performance or outcomes expressed or implied by such forward-looking statements.

No representation or warranty is given in relation to any forward-looking statements made by Derwent London, including as to their completeness or accuracy. Derwent London does not undertake to update any forward-looking statements whether as a result of new information, future events or otherwise. Nothing in this announcement should be construed as a profit forecast.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
ACQKKCBNKBKBBDB
Date   Source Headline
29th Mar 201911:00 amRNSTotal Voting Rights
28th Mar 20197:00 amRNSBrunel Building Office Space Fully Pre-Let
21st Mar 201911:00 amRNSDirector/PDMR Shareholding
20th Mar 20191:30 pmRNSBlock listing Interim Review
15th Mar 20193:00 pmRNSHolding(s) in Company
13th Mar 201910:30 amRNSDirector/PDMR Shareholding
12th Mar 201910:00 amRNSDirector/PDMR Shareholding
5th Mar 201910:30 amRNSAdditional Listing
28th Feb 20195:00 pmRNSTotal Voting Rights
27th Feb 20199:30 amRNSHolding(s) in Company
26th Feb 20195:00 pmRNSDividend Declaration
26th Feb 20197:00 amRNSRESULTS FOR THE YEAR ENDED 31 DECEMBER 2018
18th Feb 20199:00 amRNSHolding(s) in Company
31st Jan 20194:30 pmRNSTotal Voting Rights
28th Dec 20183:00 pmRNSTotal Voting Rights
13th Dec 20185:00 pmRNSHolding(s) in Company
30th Nov 20181:00 pmRNSTotal Voting Rights
30th Nov 201810:00 amRNSInvestor and Analyst Presentation and Tour
23rd Nov 20187:00 amRNSDirectorate Change
22nd Nov 20187:00 amRNS£250 Million US Private Placement
8th Nov 20187:00 amRNSQ3 2018 Business Update
7th Nov 20183:00 pmRNSHolding(s) in Company
31st Oct 20183:00 pmRNSTotal Voting Rights
17th Oct 201811:00 amRNSAdditional Listing
8th Oct 20189:43 amRNSChange of Credit Rating Agency
4th Oct 20184:00 pmRNSHolding(s) in Company
28th Sep 201811:00 amRNSTotal Voting Rights
20th Sep 20183:00 pmRNSBlock listing Interim Review
12th Sep 20185:30 pmRNSDirector/PDMR Shareholding
31st Aug 20181:00 pmRNSTotal Voting Rights
30th Aug 201811:00 amRNSAdditional Listing
28th Aug 20184:00 pmRNSDirector/PDMR Shareholding
9th Aug 20187:00 amRNSDirectorate Change
9th Aug 20187:00 amRNSHalf-year Results
31st Jul 201811:00 amRNSTotal Voting Rights
30th Jul 201810:00 amRNSHolding(s) in Company
4th Jul 201810:00 amRNSAdditional Listing
2nd Jul 201812:00 pmRNSHolding(s) in Company
29th Jun 20185:00 pmRNSDirector/PDMR Shareholding
29th Jun 20184:30 pmRNSTotal Voting Rights
14th Jun 20183:55 pmRNSSony Pictures Take Leading Role At Brunel Building
31st May 20181:00 pmRNSTotal Voting Rights
25th May 20183:00 pmRNSBlock listing Interim Review
18th May 201812:15 pmRNSResults of 2018 Annual General Meeting
16th May 201811:00 amRNSAdditional Listing
15th May 20185:30 pmRNSBondholders' meeting
10th May 20187:00 amRNSQ1 2018 Business Update
3rd May 20184:21 pmRNSAdjustment to Conversion Price
30th Apr 20186:20 pmRNSTotal Voting Rights
20th Apr 20185:30 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.